Brown Brothers Harriman & CO Pfizer Inc Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Pfizer Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 210,927 shares of PFE stock, worth $5.56 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

210,927

Previous 204,695 3.04%

Holding current value

$5.56 Million

Previous $5.73 Million 6.58%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $172,626 - $195,622	6,232 Added 3.04%	210,927 $6.1 Million
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $149,311 - $174,965	-5,911 Reduced 2.81%	204,695 $5.73 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $148,505 - $170,531	5,736 Added 2.8%	210,606 $5.84 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $740,367 - $961,655	-28,334 Reduced 12.15%	204,870 $5.9 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $149,731 - $175,021	4,666 Added 2.04%	233,204 $7.74 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $37,420 - $43,294	-1,036 Reduced 0.45%	228,538 $8.38 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $18,237 - $23,742	463 Added 0.2%	229,574 $9.37 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $1.26 Million - $1.65 Million	-30,250 Reduced 11.66%	229,111 $11.7 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $518,512 - $632,973	-11,849 Reduced 4.37%	259,361 $11.4 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $344,601 - $408,589	7,406 Added 2.81%	271,210 $14.2 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $236,527 - $293,087	-5,170 Reduced 1.92%	263,804 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $538,936 - $798,883	13,043 Added 5.1%	268,974 $15.9 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $696,412 - $894,602	-17,743 Reduced 6.48%	255,931 $11 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $164,790 - $186,680	-4,589 Reduced 1.65%	273,674 $10.7 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $2 Million - $2.26 Million	-59,825 Reduced 17.7%	278,263 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $321,245 - $408,490	9,598 Added 2.92%	338,088 $12.4 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $57,658 - $67,646	-1,816 Reduced 0.55%	328,490 $12.1 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $255,176 - $309,566	8,472 Added 2.63%	330,306 $10.8 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $791,627 - $1.13 Million	-29,287 Reduced 8.34%	321,834 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $236,793 - $268,730	7,193 Added 2.09%	351,121 $13.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $1.52 Million - $1.97 Million	46,830 Added 15.76%	343,928 $12.4 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $505,405 - $567,453	13,667 Added 4.82%	297,098 $12.9 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $163,425 - $179,549	-4,358 Reduced 1.51%	283,431 $12 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $45,625 - $52,017	-1,186 Reduced 0.41%	287,789 $12.6 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $8,203 - $9,950	238 Added 0.08%	288,975 $12.7 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $59,363 - $63,287	-1,800 Reduced 0.62%	288,737 $10.5 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $529,291 - $614,050	-16,587 Reduced 5.4%	290,537 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $325,415 - $345,277	-9,784 Reduced 3.09%	307,124 $11.1 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $334,211 - $368,171	-10,781 Reduced 3.29%	316,908 $11.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	327,689	327,689 $11 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Pfizer Inc Transaction History